CIPO Patents = 1

EPO Patents = 2

Trademarks = 1

Forward Citations = 38

Loading Chart...

9 inventors (with patents filed for the assignee):

Karin Ute Jooss (3 out of 22 patents)

Minh Nguyen (2 out of 9 patents)

Thomas Harding (2 out of 10 patents)

4. David W Frey (2 out of 15 patents)

5. Andy Lin (2 out of 3 patents)

6. Gautum Banik (2 out of 2 patents)

7. Kathryn E Koprivnikar (2 out of 3 patents)

8. Alan J Korman (1 out of 87 patents)

9. Betty Li (1 out of 3 patents)

10. James P Allison (3 patents)

11. Andrew Simmons (7 patents)

5 patents: Sort by Forward Citations

1. 9848598 - Cryoprotected, frozen recombinant cancer cells (2017-12-26),

2. 9669081 - Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer (2017-06-06),

3. 9433204 - Directly injectable formulations which provide enhanced cryoprotection of cell products (2016-09-06),

4. 8840881 - Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer (2014-09-23),

5. 8580247 - PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof (2013-11-12),

Aduro Gvax Inc. is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies. The company's lead product candidate is ADU-S100, a STING pathway activator for the treatment of solid tumors. Aduro is committed to transforming the treatment landscape for cancer patients through its innovative approach to immunotherapy.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#88 in Berkeley, CA

#11,738 in California

#50,234 in US

Berkeley, CA, United States of America

Aduro Gvax Inc.

Forward Citations = 38

9 inventors:

Karin Ute Jooss (3 out of 22 patents)

Minh Nguyen (2 out of 9 patents)

Thomas Harding (2 out of 10 patents)

4. David W Frey (2 out of 15 patents)

5. Andy Lin (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com